AsisChem to Offer Libraries through CDD!

On the heels of our announcement with ChemBridge, CDD is announcing a collaboration with AsisChem to provide libraries on CDD’s Public Access Page.

Stay tuned for more information on when the libraries are to be uploaded and what molecules they contain…

In the last month, we at CDD have released six new Data Sets on our Public Access Page!

Three of these Data Sets are from TimTec, a chemical vendor we have collaborated with before.  The first new TimTec library is their Diversity Set, a screening library of about 10,000 diverse compounds.  Second is a set of OGlcNAc Transferase Inhibitor Analogs.  Finally, TimTec’s ActiTarg-K Kinase modulators finish out the trio.  For a more detailed description of these three sets, click here.

We have also added a set of nearly 2,000 compounds screened for anti-Malaria activity (3D7 and Dd2), provided by the Johns Hopkins Clinical Compound Library.

On the Tuberculosis front, CDD’s own Sean Ekins, PhD has released a set of thirty-two 1,3 benzothiazin-4-one compounds published by Markov et. al at the NM4TB consortia.

Finally, Robert Goldman of the Southern Research Institute has made available a set of compounds screened against Mtb H37Rv.  This set of more than 200,000 compounds was collected by the Molecular Small Molecule Repository (MLSMR) in the spring of last year.

If you want to gain access to these new Data Sets, please register on our Public Access page.

The number of contributers and datasets on the Collaborative Drug Discovery platform is increasing on an ongoing basis. Not only are our users adding to the content, both public and private but we ourselves continue to assemble databases to benefit the community. Most of our efforts will result in an increase in the Public Access datasets. The present list of Public Access datasets can be found here. Keep checking this page. More datasets will be showing up shortly.